GastroPlus™

PBPK modeling software – from discovery through
development…

Watch: GastroPlus™ 9.5 Promo Video

Choose a Module:

Upcoming Webinar

Mar 28, 2017

GPUG Webinar: Use of oral absorption modelling to characterize drug release and absorption of a BCS II compound from IR formulations

View Event Details

Insight you can’t measure – the GastroPlus™ PBPK modeling & simulation package

As a researcher in the life sciences space, you can’t measure everything as a project winds its way through the R&D process. With the data that is being generated, you’re expected to make informed decisions as quickly as possible. A wrong one sets you back severely, both in terms of time and money. Now, more than ever, it is important to consider incorporating new technology across your company – like PBPK modeling.

What if it were possible to:

  • Integrate the data which has been collected and, within the context of a virtual animal or human model, gain unique insights that improve your chances for success?
  • Run simulations for different scenarios to avoid costly surprises?
  • Utilize the outputs from these models to potentially waive expensive studies requested by regulatory agencies?

It’s possible to do this, and more, with the GastroPlus PBPK modeling platform.

GastroPlus is a mechanistically based simulation software package that simulates intravenous, oral, oral cavity, ocular, inhalation, dermal/subcutaneous, and intramuscular absorption, pharmacokinetics, and pharmacodynamics in humans and animals. This smoothly integrated platform combines a user-friendly interface with powerful science to help you make faster and more informed project decisions!

GastroPlus has been separated into modules to make it easier for companies to license only the features they need in each department. The 10 modules currently available are:

What are we providing with GastroPlus?

From the beginning, a conscious decision has been made to carefully implement the best theories and develop novel approaches within the GastroPlus PBPK models. This dedication to science is a major reason why our predictions are consistently ranked #1 in independent comparisons. You provide the (limited) data, GastroPlus provides everything else:

  • Simple, intuitive user interface
  • Model customization
  • High-quality plots & figures for reporting purposes
  • Excellent customer support
  • Thriving online GastroPlus User Group to connect users and provide an online forum for sharing best practices
  • Flexible licensing models. Ask us for more details.
  • Integration with our other tools. Seamlessly define inputs for your PBPK models using the top-rated quantitative structure-activity relationship (QSAR) models from ADMET Predictor™. And, strengthen the in vitro-in vivo extrapolation of dissolution & absorption inputs with DDDPlus™ and MembranePlus™.

The in vivo processes which are considered in the GastroPlus simulations, and the methods we’ve introduced to parameterize them, are too numerous to list here – instead, take a peek at the GastroPlus datasheet for more details.

How is GastroPlus being applied?

The GastroPlus PBPK modeling platform has been utilized by companies across various industries and departments since 1998. Some of the routine applications include:

  • Screening compound libraries through the QSAR/PBPK marriage to prioritize in vivo testing
  • Predicting first-in-human (FIH)/animal doses with best-in-class IVIVE methods
  • Supporting animal or human risk assessment studies
  • Simulating steady-state and dynamic drug-drug interactions (DDI) for regulatory submissions
  • Building PBPK/PD models to estimate efficacious dose levels
  • Assisting with Quality by Design (QbD) implementation to guide product development
  • Deconvoluting in vivo dissolution for mechanistic IVIVCs
  • Understanding food effect differences
  • Conducting virtual population PK/PBPK studies & bioequivalence trials
  • Identifying appropriate dose levels and dosing regimens in diseased/pediatric populations
  • … and more!

Read about various case studies by scanning the peer-reviewed publication list! Or, have a project that would benefit from GastroPlus modeling but do not have the expertise in-house to utilize it? Schedule a call with one of our consulting experts today!

What's new in GastroPlus v9.5?

There’s something for everyone in GastroPlus v9.5, including:

  • New models for bolus & controlled release injections following subcutaneous and intramuscular administration
  • New PBPK models for antibody-drug conjugates (ADCs) – accessible through the Biologics Module
  • Updated animal physiology models for several non-oral delivery routes – available in the Additional Dosage Routes Module
  • New whole-body physiology models for Chinese (pediatric and adult) and hepatic impairment population groups in the PBPKPlus™ Module
  • Improved virtual bioequivalence trial simulation options
  • Upgraded reporting capabilities – easier interpretation for regulatory submissions
  • New PBPK models for standard substrates and inhibitors in the DDI Module
  • Enhanced parameter covariate models in the Population Simulator™
  • Corrected unbound intracellular concentrations for improved accuracy in PBPK models
  • … and more!

How do I move forward from here?

Join your peers around the world and begin working with GastroPlus to generate the insight you can’t measure to make better decisions.

Get Started